Gaujoux, Sébastien

Cystic Lesions of the Pancreas: Changes in the Presentation and Management of 1,424 Patients at a Single Institution over a 15-Year Time Period

Gaujoux, S., Brennan, M. F., Gonen, M., D’Angelica, M. I., DeMatteo, R., Fong, Y., Schattner, M., DiMaio, C., Janakos, M., Jarnagin, W. R., et al. (2011) · Journal of the American College of Surgeons

Pancreatitis Pathology and TreatmentPancreatic and Hepatic Oncology Research

Cited by 224

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review

Ozola Zalite, I., Zykus, R., Francisco Gonzalez, M., Saygili, F., Pukitis, A., Gaujoux, S., Charnley, R. M., & Lyadov, V. (2015) · Pancreatology

Nutrition and Health in AgingPancreatic and Hepatic Oncology Research

Cited by 174

Transcriptome analysis reveals that p53 and β-catenin alterations occur in a group of aggressive adrenocortical cancers

Ragazzon, B., Libé, R., Gaujoux, S., Assié, G., Fratticci, A., Launay, P., Clauser, E., Bertagna, X., Tissier, F., de Reyniès, A., et al. (2010) · Cancer Research

Adrenal and Paraganglionic TumorsChromatin Remodeling and Cancer

Cited by 152

β-Catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma

Gaujoux, S., Grabar, S., Fassnacht, M., Ragazzon, B., Launay, P., Libé, R., Chokri, I., Audebourg, A., Royer, B., Sbiera, S., et al. (2011) · Clinical Cancer Research

Adrenal and Paraganglionic TumorsChromatin Remodeling and Cancer

Cited by 146

Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors

Gaujoux, S., Tissier, F., Groussin, L., Libé, R., Ragazzon, B., Launay, P., Audebourg, A., Dousset, B., Bertagna, X., & Bertherat, J. (2008) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsChromatin Remodeling and Cancer

Cited by 142

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors

Bonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher-Lavenu, M.-C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 133